Rafarma Pharmaceuticals, Inc. (RAFA)
OTCMKTS · Delayed Price · Currency is USD
0.0675
+0.0041 (6.47%)
Aug 18, 2025, 9:30 AM EDT
Rafarma Pharmaceuticals Revenue
In the fiscal year ending March 31, 2012, Rafarma Pharmaceuticals had annual revenue of $133.33K.
Revenue
133.33K
Revenue Growth
n/a
P/S Ratio
41.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2012 | 133.33K | - | - |
| Mar 31, 2011 | 133.33K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRafarma Pharmaceuticals News
- 5 months ago - Rafarma Pharmaceuticals to Present at the Virtual Life Science Investor Forum March 13th - GlobeNewsWire
- 1 year ago - Rafarma pharmaceutical updates: registration of Rafarma microspheres in South Korea - GlobeNewsWire
- 1 year ago - Rafarma pharmaceutical updates: creation of a joint research and production enterprise in Busan (South Korea) between Rafarma and the Korean pharmaceutical company Woods Medical Care - GlobeNewsWire
- 1 year ago - Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University - GlobeNewsWire
- 1 year ago - Rafarma Pharmaceutical news update - GlobeNewsWire
- 3 years ago - Rafarma Pharmaceuticals strengthens its position in Central Asia - GlobeNewsWire
- 3 years ago - Rafarma's Slavich Noya Technology Division Expands Printing Production - GlobeNewsWire
- 3 years ago - RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research - GlobeNewsWire